Amgen

Which Big Pharma Stocks Lose Most in a War on Drug Price Hikes?
Yahoo/Motley Fool
Sun, 01/20/19 - 03:20 pm
drug pricing
Big Pharma
Amgen
AstraZeneca
Pfizer
GSK
Merck
Gilead
Amgen's once-dismissed osteoporosis drug Evenity 'back in the game' after rosy FDA panel vote
Fierce Pharma
Thu, 01/17/19 - 12:06 am
Amgen
osteoporosis
Evenity
romosozumab
FDA
advisory panels
FDA staff largely unfazed by CV signal in Amgen osteoporosis drug trials
Endpoints
Mon, 01/14/19 - 11:37 pm
Amgen
osteoporosis
FDA
romosozumab
clinical trials
Can Botox hang with CGRP in migraine? Allergan says yes; analysts are skeptical
Fierce Pharma
Mon, 01/14/19 - 11:11 am
Allergan
Botox
migraines
CGRP blockers
Amgen
Novartis
Aimovig
Teva Pharmaceutical
Ajovy
Eli Lilly
Emgality
NICE turns down Novartis' Aimovig, flagging clinical trial concerns
Biopharma Dive
Fri, 01/11/19 - 08:18 pm
NICE
UK
Amgen
Novartis
migraines
Aimovig
Amgen touts lowered prices for Repatha delivery devices
Drug Delivery Business News
Tue, 01/8/19 - 07:20 pm
Amgen
drug delivery
Repatha
Could Gilead, Amgen and AbbVie follow Bristol-Myers into megadeal territory?
Fierce Pharma
Sat, 01/5/19 - 01:34 pm
M&A
Bristol-Myers Squibb
Celgene
Gilead Sciences
AbbVie
Amgen
Here's Why bluebird bio Shares Got Knocked Down 19.3% in December
Motley Fool
Sat, 01/5/19 - 12:05 am
Bluebird Bio
ASH2018
AMG 420
Amgen
Amgen pays $50M for Molecular Partners’ preclinical bispecific
Fierce Biotech
Wed, 12/19/18 - 10:07 am
Amgen
Molecular Partners
MP0310
15 For ’19: Key Clinical Data To Watch For Next Year (Part 1)
Xconomy
Mon, 12/17/18 - 09:44 am
clinical trials
Alzheimer's disease
Biogen
Duchenne Muscular Dystrophy
Pfizer
Solid Biosciences
Sarepta Therapeutics
hemophilia A
Biomarin
Multiple Myeloma
Celgene
Bluebird Bio
Amgen
solid tumors
Bristol-Myers Squibb
Nektar Therapeutics
age-related macular degeneration
Regenxbio
SAGE Therapeutics
MorphoSys
Amgen teams with Entera to develop oral biologics
Fierce Biotech
Wed, 12/12/18 - 12:24 am
Amgen
Entera Bio
biologics
drug development
Amgen Contributes to Nonprofit to Support Greater Diversity in Clinical Trials
BioSpace
Wed, 12/12/18 - 12:19 am
Amgen
clinical trials
diversity
minorities
oncology
Rheostat Therapeutics Raises $23 Million from Heavyweight Pharma Companies in Series A Round
CP Wire
Mon, 11/26/18 - 10:21 am
Rheostat Therapeutics
Merck
AbbVie
Amgen
Pfizer launches biosimilar version of Amgen's Epogen
Biopharma Dive
Wed, 11/14/18 - 11:45 pm
Pfizer
biosimilars
Amgen
Epogen
JNJ
Procrit
anemia
Merck, Amgen back a $30M play for Ribometrix — one of the upstarts making its mark in drugging RNA
Endpoints
Tue, 11/13/18 - 09:55 am
Merck
Amgen
Ribometrix
RNA
Coherus prices biosimilar to Amgen's Neulasta at 33 percent discount
Reuters
Fri, 11/9/18 - 12:03 pm
Coherus Biosciences
Amgen
biosimilars
Neulasta
3 Cancer Stocks to Watch in December
Motley Fool
Wed, 11/7/18 - 10:06 am
Acceleron
luspatercept
Bluebird Bio
bb21217
Amgen
AMG 420
Coherus looks to disrupt Amgen’s $4B Neulasta franchise as analysts look for a deep discount on its copycat price
Endpoints
Mon, 11/5/18 - 09:56 am
Coherus
Neulasta
Mylan
biosimilars
Amgen
Amgen reckons with biosimilar and pricing pressures
Biopharma Dive
Wed, 10/31/18 - 07:14 pm
Amgen
earnings
biosimilars
Aimovig
Aging Blockbusters Send Amgen Inc.'s Bottom Line Lower
Motley Fool
Tue, 10/30/18 - 11:15 pm
Amgen
earnings

Pages